Wilmington, DE, United States of America

Tyme, Inc.


USPTO Granted Patents = 21

% Expired Patents = 47.6


Trademarks = 1

Forward Citations = 68

Loading Chart...
Loading Chart...

3 inventors (with patents filed for the assignee):

goldMedal Steven P Hoffman (16 out of 41 patents)

silverMedal Jacynda Smith (5 out of 5 patents)

bronzeMedal John Rothman (2 out of 23 patents)


21 patents:

Company Overview
Tyme, Inc. is a biotechnology company focused on developing innovative therapies for cancer treatment. The organization specializes in the research and commercialization of novel drug candidates that leverage its proprietary technology platform. Based in Wilmington, Delaware, Tyme aims to address unmet medical needs in oncology through its unique approach to drug development, which emphasizes precision medicine and targeted therapies. The company's commitment to advancing cancer care positions it as a key player in the biopharmaceutical landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Tyme, Inc. USPTO Patent Assignee Logo
21 Patents

#211 in Wilmington, DE

#260 in Delaware

#15,681 in US

#29,928 in the World

Wilmington, DE (US)
Wilmington, DE, United States of America
Forward Citations = 68

3 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Tyme, Inc.. Retrieved from https://idiyas.com/company/tyme

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…